NOS3 and obesity disorder: This is a known phenomenon seen in obesity and HFD feeding, in which there is suppression of eNOS production through down regulation of the AMP-activated protein kinase pathway, correlating with serum TAG levels and glucose tolerance profiles, as a means of modulating energy storage42,43.